KRAS and neoplasm: In line with a previous study describing a protective role for the PERK pathway upon antimetabolites treatment [24], our results indicate that harsh nutritional microenvironment, reflecting the tumor glucose concentration, indeed protects against PEM in a lung cancer model mutated for KRAS.